Veterinary Medicines

Biocan LR inj. ad us. vet. suspensija injekcijai suņiem

Authorised
  • Rabies virus, Inactivated
  • LEPTOSPIRA ICTEROHAEMORRHAGIAE INACTIVATED
Download as PDF

Product identification

Medicine name:
Biocan LR inj. ad us. vet. suspensija injekcijai suņiem
Active substance:
  • Rabies virus, Inactivated
  • LEPTOSPIRA ICTEROHAEMORRHAGIAE INACTIVATED
Target species:
  • Dog
Route of administration:
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, Inactivated
    1.00
    international unit(s)
    /
    1.00
    millilitre(s)
  • LEPTOSPIRA ICTEROHAEMORRHAGIAE INACTIVATED
    40000000.00
    international unit(s)
    /
    1.00
    millilitre(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AL01
Legal status of supply:
This information is not available for this product.
Authorisation status:
  • Valid
Authorised in:
  • Latvia
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Legal basis reviewed according to Acquis communautaire
Marketing authorisation holder:
  • Bioveta a.s.
Marketing authorisation date:
Manufacturing sites for batch release:
  • Bioveta a.s.
Responsible authority:
  • PVD
Authorisation number:
  • V/NRP/01/1333
Date of authorisation status change:

Documents

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 7/12/2021
Download

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Latvian (PDF)
Published on: 14/03/2022
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."